TER.NASDAQTeradyne, INC

Form 4: Teradyne Robotics President Receives Equity Grants

Sentiment:

Insider Transaction Disclosure


Teradyne's President of Robotics, Jean Pierre Hathout, was granted 1,004 restricted stock units and options to purchase 886 shares of common stock.

Summary

  • Jean Pierre Hathout, President of Teradyne Robotics, received a grant of 1,004 Restricted Stock Units (RSUs) on February 4, 2026.
  • Each RSU represents the right to receive one share of Teradyne Common Stock.
  • These RSUs will vest in four equal annual installments, commencing on February 4, 2027.
  • Additionally, Hathout was granted stock options to acquire 886 shares of Common Stock on February 4, 2026.
  • The exercise price for these stock options is $269.07 per share.
  • The stock options will vest 25% per year over four years, also beginning on February 4, 2027, and expire on February 4, 2033.
  • Following these transactions, Hathout beneficially owns 10,174 shares of Common Stock and 886 derivative securities (stock options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that aim to align management incentives with shareholder interests for long-term value creation.

Positives

  • The grant of 1,004 Restricted Stock Units (RSUs) and options for 886 shares aligns the executive's interests with long-term shareholder value.
  • Equity compensation is a standard practice to incentivize key management personnel.

Future Outlook

The vesting schedules for the RSUs and stock options, extending to February 4, 2027, and beyond, indicate a long-term incentive structure designed to retain the executive and align their performance with the company's future success over several years.

Industry Context

StockSavvy.ai notes that the grant of restricted stock units and stock options to a key executive like the President of Teradyne Robotics is a standard practice within the technology and industrial automation sectors. This form of equity compensation is widely used to attract, retain, and motivate senior leadership, linking their financial incentives directly to the company's stock performance and long-term strategic goals.

Comparison to Industry Standards

  • The structure of equity grants, including RSUs and stock options with multi-year vesting schedules, is consistent with compensation practices observed at comparable technology companies such as KLA Corporation, Applied Materials, and Lam Research, which frequently utilize similar long-term incentive plans for their executives to foster retention and performance alignment.
  • The vesting period of four years for both RSUs and options is a common industry standard, aiming to ensure sustained executive commitment.

Related Party Transactions

  • The grant of equity compensation to Jean Pierre Hathout, an officer of Teradyne, Inc., constitutes a related party transaction, which is a standard component of executive compensation packages.

Stakeholder Impact

  • Shareholders: Potential for long-term value alignment with management, but also potential for minor dilution from future share issuance upon vesting/exercise.
  • Management: Increased personal stake in the company's performance and long-term retention incentive.

Next Steps

  • The Restricted Stock Units will begin to vest in four equal annual installments starting February 4, 2027.
  • The stock options will begin to vest 25% per year over four years, starting February 4, 2027.

Key Dates

DateDescription
02/04/2026Date of grant for Restricted Stock Units (RSUs) and stock options.
02/06/2026Date the Form 4 was signed by the attorney-in-fact.
02/04/2027First anniversary of the grant date, when the first installment of RSUs and stock options will vest.
02/04/2033Expiration date for the granted stock options.

Keywords

Teradyne, TER, Form 4, insider transaction, restricted stock units, RSUs, stock options, executive compensation, equity grant, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.